ALD	alcoholic liver disease;
ALT	alanine amino transferase;
BCL2	B-cell lymphoma 2;
MCL1	myeloid cell lymphoma 1;
BDNR	brain-derived neurotropic factor;
CB1R	cannabinoid receptor 1;
CCL2	chemokine (c-c motif) ligand 2;
CYP2E1	cytochrome p450-2E1 oxidase;
DR5	death receptor 5;
DGCR8	DiGeorge syndrome critical region 8;
RBC	red blood cells;
ROS	reactive oxygen species;
FAEE	fatty acid ethyl ester;
FASLG	FAS ligand G;
FoxM1	forkhead box protein M1;
LCFA	long chain fatty acids;
IL	interleukin;
lncRNA	long non-coding RNA;
LPS	lipopolysaccharide;
MALAT1	metastasis associated lung adenocarcinoma transcript 1;
PGC-1α	peroxisome proliferator-activated receptor 1 alpha;
RAR	retinoic acid receptor;
STAT3	signal transducer and activator of transcription 3;
SCFA	short chain fatty acids;
SOCS1	suppressor of cytokine signaling1;
SIRT	Sirtuins;
SREBP	sterol regulatory element-binding protein;
TLR4	toll-like receptor 4;
TGF-β	transforming growth factor-β;
TNF-α	tumor necrosis factor-α;
TBX5	T-box transcription factor 5;
UTR	un-translated region;
VLDL	very low density lipoproteins;
ZO-1	zona occludens.